Comera Life Sciences Inc... (CMRA)
0.00
-0.00 (-100.00%)
At close: Mar 26, 2025, 12:42 PM
-100.00% (1D)
| Bid | n/a |
| Market Cap | 6.15K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.22 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 222 |
| Avg. Volume (20D) | 788 |
| Open | 0.00 |
| Previous Close | 0.00 |
| Day's Range | 0.00 - 0.00 |
| 52-Week Range | 0.00 - 0.06 |
| Beta | -20.43 |
About CMRA
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis dis...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 21, 2020
Employees 12
Stock Exchange OTC
Ticker Symbol CMRA
Website https://comeralifesciences.com
2 years ago · pennystocks.com
3 Hot Penny Stocks To Buy According To Insiders In SeptemberPenny stocks to buy? That's what these insiders think.
2 years ago · investorplace.com
Insiders Are Buying Up Comera Life Sciences (CMRA) Stock. Here's Why.Shares of Comera Life Sciences (NASDAQ: CMRA ) are up by over 30% following a flurry of insider purchases. As the name suggests, Comera is a life sciences company that seeks to improve traditional int...
